Altria Group (MO)
(Delayed Data from NYSE)
$49.42 USD
+0.30 (0.61%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $49.61 +0.19 (0.38%) 9:22 AM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$49.42 USD
+0.30 (0.61%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $49.61 +0.19 (0.38%) 9:22 AM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
Altria's (MO) Q3 Earnings Miss Estimates on Soft Volumes
by Zacks Equity Research
Altria's (MO) third-quarter 2023 results reflect lower shipment volumes as a result of macroeconomic pressure on ATC behavior. However, pricing remains an upside.
Altria (MO) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -0.78% and 3.70%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Altria (MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, Altria (MO) closed at $42.71, indicating a +0.23% shift from the previous trading day.
What to Know About Altria (MO) as It Queues for Q3 Earnings?
by Zacks Equity Research
Altria's (MO) third-quarter results are likely to reflect gains from pricing and strength in oral tobacco products amid soft cigarette volumes.
Altria (MO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $42.61, representing a -1.18% change from its previous close.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
(MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.66, marking a +0.99% move from the previous day.
Altria (MO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Altria (MO) reachead $42.24 at the closing of the latest trading day, reflecting a -0.75% change compared to its last close.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Altria (MO) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $42.07, representing a +0.19% change from its previous close.
(MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, Altria (MO) closed at $41.99, indicating a +0.82% shift from the previous trading day.
Altria (MO) Poised on Pricing Power Amid Soft Cigarette Volumes
by Zacks Equity Research
Altria (MO) benefits from its diverse portfolio of smoke-free products and competitive pricing strategies amid soft cigarette volumes.
Time to Buy These Popular High-Dividend Yielding Stocks?
by Shaun Pruitt
Three stocks that are able to lure investors in with their lofty dividends are Simon Property Group (SPG), Altria (MO), and OneMain Holdings (OMF).
Altria (MO) Stock Moves -0.21%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.05, marking a -0.21% move from the previous day.
Altria (MO) Stock Moves 0.02%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $41.91, marking a +0.02% move from the previous day.
Top Stock Reports for Amazon.com, Boeing, Regeneron & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Boeing Company (BA) and Regeneron Pharmaceuticals, Inc. (REGN).
Altria (MO) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $42.91, moving -0.3% from the previous trading session.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $43.53, marking a -1.29% move from the previous day.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $44.10, moving -1.45% from the previous trading session.
Altria (MO) Is Marching Ahead of the Industry: Will This Stay?
by Zacks Equity Research
Altria (MO) is positioned to keep benefiting from its smoke-free products and pricing strategy. Management targets nearly doubling its smoke-free net revenues to $5 billion by 2028.
Dividend Watch: 3 Companies Boosting Payouts
by Derek Lewis
Shareholders can receive many positive announcements, such as upgraded guidance or news of a hot acquisition. Of course, dividend raises also fall into this category.
Zacks Industry Outlook Highlights Philip Morris, Altria, Turning Point Brands and 22nd Century
by Zacks Equity Research
Philip Morris, Altria, Turning Point Brands and 22nd Century have been highlighted in this Industry Outlook article.
4 Tobacco Stocks Worth Watching Despite Industry Concerns
by Vrishali Bagree
The Zacks Tobacco industry players battle concerns surrounding soft cigarette volumes and high input costs, while pricing power and smoke-free products aid. Philip Morris (PM), Altria Group (MO), Turning Point (TPB) and 22nd Century Group (XXII) look well-placed.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $44.08, marking a +0.82% move from the previous day.